
Alan Tall
Chief, Molecular Medicine · New York Presbyterian Hospital
Credentials: · ·
History
PresentMolecular Medicine Division · New York Presbyterian Hospital


- 1974–1975

- 1972–1973
Research
Biological, clinical and population relevance of 95 loci for blood lipids
Systematic review or meta-analysis · Nature · 2010 · 2,901 citations
Effects of torcetrapib in patients at high risk for coronary events
New England Journal of Medicine · 2007 · 2,564 citations
Cholesterol, inflammation and innate immunity
Review · Nature reviews. Immunology · 2015 · First of 2 authors · 1,203 citations

86 papers · 18 as a resident

43 papers
- JB
24 papers

16 papers
- DS
14 papers

13 papers
- RD
12 papers

12 papers
Grants
- 2024–2029
Cellular and Molecular Mechanisms of Atherosclerosis
National Heart, Lung, and Blood Institute · P01
Contact PI · $7M · Columbia University Health Sciences
- 2021–2029
Clonal Hematopoiesis, Inflammasomes and Atherosclerosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.7M · Columbia University Health Sciences
- 2011–2027
Cholesterol Efflux, CHIP and Inflammasome Activation
National Heart, Lung, and Blood Institute · R01
Contact PI · $7.7M · Columbia University Health Sciences
- 2023–2027
New Therapeutic Approaches in Clonal Hematopoiesis and Atherosclerosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $694.7K · Columbia University Health Sciences

